Latest news Latest news Latest news

Latest news

Portfolio

B+N acquires KÖBERL Group, a leading provider of facility management and technical building services, from Gimv

18/12/2024 - 07:30

Portfolio

Belgian software company Itineris accelerates expansion in the U.S.

13/12/2024 - 09:35

Portfolio

Gimv acquires Groupe Tibbloc, leader in rental of ready-to-use temporary energy solutions and related services, from Ciclad

04/12/2024 - 07:30

Portfolio

Gimv invests in the further growth and internationalization of Lupine Lighting Systems

02/12/2024 - 07:30

Corporate

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

21/11/2024 - 06:58

Portfolio

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

20/11/2024 - 07:45

Portfolio

Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates

28/10/2024 - 17:45

Portfolio

Brouwerij Martens acquires United Dutch Breweries with a purpose of further joint global expansion

16/10/2024 - 07:45

Portfolio

Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease

15/10/2024 - 11:55

Portfolio

Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)

19/09/2024 - 17:45

Portfolio

ImCheck Receives FDA Fast Track Designation for ICT01 in Combination with Azacitidine and Venetoclax in First-Line Acute Myeloid Leukemia for Patients Unfit for Induction Chemotherapy Treatment

18/09/2024 - 11:38

Portfolio

ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base

17/09/2024 - 17:01

Contact information

Investor Relations

Do you have any questions or require more information? Please contact us.